The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
Expert Testimony - Abbvie
Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study.
 
Anuj K. Patel
Consulting or Advisory Role - Eisai
Research Funding - Analysis Group (Inst)
Travel, Accommodations, Expenses - Eisai
 
Kimmie Ng
Consulting or Advisory Role - Bayer; Genentech/Roche; Lilly; Seagen; Tarrex Biopharma
Research Funding - Celgene; Genentech/Roche (Inst); Gilead Sciences; Pharmavite (Inst); Trovagene
 
Mei Sheng Duh
No Relationships to Disclose
 
Victoria E. Barghout
Employment - VEB HealthCare
Consulting or Advisory Role - Eisai; Novartis; Taiho Pharmaceutical
 
Lynn Huynh
Research Funding - Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Mihran Ara Yenikomshian
Research Funding - Abbvie (Inst); Genentech (Inst); Taiho Pharmaceutical (Inst)
 
Camara Sharperson
Research Funding - Taiho Pharmaceutical (Inst)
 
Lauren K. Brais
No Relationships to Disclose
 
Charles S. Fuchs
Consulting or Advisory Role - Agios; Bayer; Dicerna; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; KEW; Lilly; Merck; Merrimack; Sanofi; Taiho Pharmaceutical